Hao Sun

Mr. Hao Sun

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2016 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
PDF file
ZXZheng Xiang
Zheng Xiang
HSHao Sun
Hao Sun
XCXiaojun Cai
Xiaojun Cai
DCDahui Chen
Dahui Chen

20 November 2025 in European Journal of Pharmacology
Verified
Journal Article
Open access
YGYi Gao
Yi Gao
DWDan Wang
Dan Wang
ZYZheng Yongquan
Zheng Yongquan
HSHao Sun
Hao Sun
Betulinic acid (BA), a naturally occurring pentacyclic triterpenoid, exhibits remarkable bidirectional regulatory effects on apoptosis, demonstrating pro-apoptotic activity in cancer cells while protecting normal cells from oxidative stress and apoptosis. This systematic review synthesizes decade-long research to elucidate BA's multifaceted mechanisms across apoptosis-related pathways. In malignant cells, BA induces caspase-dependent apoptosis through both extrinsic pathways mediated by FADD via death receptor activation and intrinsic mechanisms involving ROS accumulation, Bcl-2 family-mediated mitochondrial dysfunction, and ERS-triggered PERK activation. Concurrently, it suppresses PI3K-Akt and NF-κB survival signaling while activating AMPK/mTOR-autophagy crosstalk and p53-dependent DNA damage responses. Paradoxically, BA protects normal tissues by enhancing antioxidant defenses through Nrf2/SOD activation, inhibiting pro-inflammatory TNF-α/NF-κB signaling, and stabilizing mitochondrial integrity. Key to its therapeutic potential is the context-dependent modulation of critical nodes that balance apoptosis initiation and cytoprotection. Structural derivatives and nano-formulations further enhance BA's tumor selectivity and bioavailability. By mapping BA's pleiotropic interactions within apoptotic networks, this review highlights its unique capacity to function as a precision therapeutic agent, offering dual cytostatic and cytoprotective benefits. These insights position BA as a promising candidate for cancer therapy development, warranting further investigation into pathway crosstalk and clinical translation strategies.

21 July 2022 in Natural Product Communications
Verified
Journal Article
Open access
DWDan Wang
Dan Wang
MXMengjin Xu
Mengjin Xu
FLFan Li
Fan Li
YGYi Gao
Yi Gao
HSHao Sun
Hao Sun
Cervical cancer is the fourth most common female malignancy with high morbidity and mortality, which urgently needs novel anti-cancer drugs. Accumulating investigations have focused on the antitumor activity of betulinic acid (BA), which is a natural compound with low toxicity and high efficiency. Although the effect of BA on SiHa cells is obvious, the specific mechanism is seldom studied. Target identification is an important part of research on the internal mechanism of action. In this current study, an integrated method based on literature collection, target prediction, enrichment analysis, network analysis, and western blotting experiments was performed to identify the potential key targets of BA-induced apoptosis. Then, combined with the identified potential key targets, the specific mechanism of BA-induced cervical cancer SiHa cells apoptosis was elucidated. Our present study demonstrated that BA significantly reduces the viability of cervical cancer SiHa cells in a dose- and time-dependent manner. In addition, 8 potential key targets (AKT1, CASP8, LMNA, TNF, BCL2, CASP3, PARP1, and XIAP) were obtained through our integrated target identification method. Meanwhile, western blotting showed that within a certain concentration range, the expression of cleaved-caspase 3, cleaved-PARP, and cytochrome c increased with the BA concentration, while XIAP was almost unchanged. Therefore, the effect of BA on cervical cancer is noticeable. BA-induced SiHa cells apoptosis is a multi-molecule coordinated process. In this process, BA is not only a participant in either the extrinsic or intrinsic pathways, but also a regulator of apoptosis effector molecules of the CASP3/PARP1 axis.

4 April 2016 in Journal of Chromatographic Science
Verified
Journal Article
Open access
PDF file
DCDahui Chen
Dahui Chen
HSHao Sun
Hao Sun
JSJiaqi Shen
Jiaqi Shen
LILongo Phemba Igor
Longo Phemba Igor
XZXiaoyong Zheng
Xiaoyong Zheng
ZXZheng Xiang
Zheng Xiang
Rosavin is a bioactive antidepressant component isolated from Rhodiola rosea L. In this work, an ultra-performance liquid chromatography (UPLC) method was established for the determination of rosavin in rat plasma. The chromatographic separation was achieved on a HSS T3 column (100 mm × 2.1 mm, 1.8 μm) with a gradient mobile phase consisting of acetonitrile and water (0.1% formic acid). Plasma samples were processed with one-step protein precipitation. Rutin was chosen as internal standard and the detection wavelength was 249 nm. The pharmacokinetic parameters were analyzed using the drug and statistics software. The results showed that the established method has an excellent linearity in the range of 10–1,000 ng/mL (R2 = 0.992) with a lower limit of quantification (10 ng/mL). The intra- and interday precision (relative standard deviation) were from 2.0 to 10.6% and the extraction recovery was 92.4–95.1%. The simple and rapid UPLC method was successfully applied to the pharmacokinetic and bioavailability study of rosavin in rats.

1 October 2020 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
YSYiting Shen
Yiting Shen
FFFeng Feng
Feng Feng
HSHao Sun
Hao Sun
GLGuowei Li
Guowei Li
ZXZheng Xiang
Zheng Xiang

1 August 2022 in Current Computer-Aided Drug Design
Verified
Journal Article
Closed access
PDF file
HSHao Sun
Hao Sun
DWDan Wang
Dan Wang
MXMengjin Xu
Mengjin Xu
YGYi Gao
Yi Gao
FLFan Li
Fan Li
Background: The screening of effective ingredients is the bridge between the research of efficacy and the mechanism of traditional Chinese medicine. Although promising virtual screening has emerged as an attractive alternative, an ideal strategy is still urgently required due to the characteristics of multi-ingredients and multi-targets of traditional Chinese medicine.Objective: The aim of the study was to develop a methodological verification-based novel screening strategy capable of comprehensively assessing the ability of compounds to perturb disease networks, thereby identifying representative ingredients of traditional Chinese medicine interventions in complex diseases.Methods: In this article, we take astragalus interfering with cervical cancer as an example. First, a multifunctional clustering disease network model was constructed; second, the several drugs and their decoys were used for molecular docking with disease network clusters for methodological verification and determining the best scoring criteria. Third, the representative ingredients of astragalus were screened according to the best scoring criteria. Finally, the effects of the representative ingredients on cervical cancer SiHa cells were evaluated by CCK-8 assay, flow cytometry, and western blot analysis.Results: Three representative ingredients of astragalus were betulinic acid, hederagenin and methylnissolin, which perturbed the apoptosis, stabilization of p53, and G1/S transition cluster as a whole, respectively. CCK-8 assay showed that the IC50 value of betulinic acid, hederagenin and methylnissolin at 48 h was 28.84, 101.90, and 187.40 μM, respectively. Flow cytometry showed that these three representative ingredients could significantly induce early apoptosis and cell cycle arrest. Western blot analysis showed that betulinic acid treatment significantly increased p53 expression, while hederagenin and methylnissolin did not.Conclusions: This study has provided new ideas for the screening of effective ingredients in traditional Chinese medicine, and established a foundation for elucidating the overall mechanism of action of traditional Chinese medicine